Esin, E. Et Al. 2018. Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results. 43rd ESMO Congress (ESMO) , (Munich, Germany), 104-105.

Esin, E., Oksuzoglu, O. B. C., Bilici, A., ÇİÇİN, İ., AKSOY, S., Alacacioglu, A., ... Kaplan, M. A.(2018). Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results . 43rd ESMO Congress (ESMO) (pp.104-105). Munich, Germany

Esin, E. Et Al. "Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results," 43rd ESMO Congress (ESMO), Munich, Germany, 2018

Esin, E. Et Al. "Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results." 43rd ESMO Congress (ESMO) , Munich, Germany, pp.104-105, 2018

Esin, E. Et Al. (2018) . "Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results." 43rd ESMO Congress (ESMO) , Munich, Germany, pp.104-105.

@conferencepaper{conferencepaper, author={E. Esin Et Al. }, title={Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results}, congress name={43rd ESMO Congress (ESMO)}, city={Munich}, country={Germany}, year={2018}, pages={104-105} }